ReviewImmunoTargets and therapy2026

Advances in the Management of Mediator-Related Symptoms in Non-Advanced Systemic Mastocytosis.

Theo Gülen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.